NCT00129428View on ClinicalTrials.gov

Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
KeloidScleroderma, LocalizedAcne KeloidalisScarsGranuloma Annulare
Interventions
PROCEDURE

UVB Irradiation

A dose of up to 320 mJ/cm2 from a UVB irradiation device will be administered at maximum 5 times per week for 16 weeks.

Trial Locations (1)

48109

University of Michigan Department of Dermatology, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT00129428 - Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix | Biotech Hunter | Biotech Hunter